Clinical trial NCT06350721: Feasibility, Usability and Safety of the Vestibular Rehabilitation Using the Immersive Virtual Reality Software DizzyVR
Official title: Feasibility, Usability and Safety of the Vestibular Rehabilitation Using the Immersive Virtual Reality Software DizzyVR
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: NA
Conditions: Vestibular Disorder
Physical Disability
Keywords: Virtual reality
Vestibular
Head Mounted Display
DizzyVR
Lead sponsor: Universidad Loyola Andalucia
Sponsor class: OTHER
Collaborators: name: University of Seville
name: Universitat Politècnica de València
name: Universidad de Zaragoza
First posted: 2024-04-05
Enrollment: 10
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: DEVICE_FEASIBILITY

Brief summary: The goal of this pilot study is to assess the safety and feasibility of the immersive virtual reality system called DizzyVR in participants diagnosed with a vestibular disorder. The main questions it aims to answer are:

* To assess the feasibility, usability and safety of the system DizzyVR for the vestibular rehabilitation in participants with vestibular disorders.
* To detect and record possible adverse events due to the use of DizzyVR.
* To examine the degree of adherence of the participants to the intervention.
* To know the average success rate of the different games in each session.
* To evaluate the average difficulty levels overcome throughout the intervention.
* To know the usability and satisfaction with the system reported by participants and therapists.

Participants will receive the vestibular rehabilitation based on the novel immersive virtual systema, DizzyVR.

Detailed description: Once the patient is received in the physiotherapy area of the Vertigo Unit, the researchers will proceed to provide the informational sheet and informed consent, as well as verbally explain the project. After the informed consent is signed, the researchers will collect all descriptive variables, as well as the baseline score of the DHI questionnaire (T0). During the course of the research, the researchers will daily record participants' attendance, the overall percentage of correct answers in each session, the occurrence of undesired effects, and the score of the Simulator Sickness Questionnaire (T1). In the final physiotherapy session (T2), each participant will re-evaluate the DHI questionnaire, as well as the perceived usability questionnaire of the system (SUS) and the virtual systems satisfaction evaluation questionnaire (USEQ). Finally, approximately 15 days after the intervention concludes, participants will be scheduled for in-depth individual perceptions about the system through a semi-structured interview (T3). With the same purpose, after the period of using the DizzyVR system, the researchers will interview the physiotherapists who have participated in this study (T4).

Each patient will receive a total of 8 sessions of vestibular rehabilitation with the DizzyVR system. Each session will last for 50 minutes, with a frequency of one session per week. The total duration of the intervention will be 10 weeks, with the initial assessment/T0 taking place in the first week and the final assessment/T2 in the tenth week. Similarly, the total expected participation time for each participant is set at 12 weeks (T3).

Eligibility criteria: Inclusion Criteria:

* Men or women between the ages of 18 and 65.
* Confirmed diagnosis of central or peripheral vestibulopathy.
* Preserved walking ability.
* Presence of mild to moderate dizziness as assessed by the Dizziness Handicap Inventory (≤ 60 points).

Exclusion Criteria:

* Severe visual impairments.
* Cognitive impairment (Mini Mental State Examination \< 24) \[34\].
* Existence of comorbidities severely affecting postural control and balance.
* Uncontrolled systemic diseases that contradict physical activity.

Primary outcomes:
measure: Retention rate of participants
timeFrame: 10 weeks
measure: User Satisfaction Evaluation Questionnaire (USEQ)
timeFrame: 10 weeks
measure: Register of risk and number of adverse events experimented by the stakeholders
timeFrame: 10 weeks
measure: Adherence rate
timeFrame: 10 weeks
measure: Dropout rates
timeFrame: 10 weeks
Secondary outcomes:
Other outcomes:
Locations:
Study officials:
References: